20159 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Exosome delivery technology
#302Targeting of innate immune response to tumor site
#303Immediate release abuse-deterrent granulated dosage forms
#304Controlled release dosage form for once daily administration of dimethyl fumarate
#305MICROPARTICLES, BLOOD SUBSTITUTE AND METHOD FOR FORMING SAME
#306Co-encapsulation of live cells with oxygen-generating particles
#307Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#308Multilayer solid pharmaceutical dosage forms
#309Ionic gelation on solids
#310Particles comprising a shell with RNA
#311Solid drug implants for intracochlear delivery of therapeutics for the treatment of Otic disorders
#312Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#313Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#314Photosensitive capsules and cosmetic and pharmaceutical use thereof
#315Compositions and methods for administration to subjects with dysphagia
#316Encapsulated cells for hormone replacement therapy
#317Layered sustained-release microbeads and methods of making the same
#318Compositions for treatment of attention deficit hyperactivity disorder
#319Semi-permeable encapsulation system with tapered conduits for diabetes reversal
#320Compositions for treatment of attention deficit hyperactivity disorder
#321Pharmaceutical formulation for bedwetting and method of use thereof
#322Pharmaceutical cyclosporin compositions
#323Encapsulated cells for hormone replacement therapy
#324Composition comprising oil drops
#325Functional polymer film-coated particle having high drug content, tablet containing same, and methods for production thereof
#326Method of preparing drug agglomerate
#327Preventing whisker growth from an L-menthol composition
#328Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
#329Probiotic liquid food products for infants
#330Pharmaceutical compositions of tamsulosin or salts thereof
#331Composition for the treatment of disease
#332Formulations
#333Zoo-Technical Drug Delivery Device
#334Enteric coated multiparticulate composition with proteinaceous coating for improved storage stability
#335Encapsulation of hydrophobic biologically active compounds
#336Multifunctional nanoparticle designs and applications
#337L-menthol dosage forms having a proteinaceous coating for enhanced storage stability
#338Multiparticulate L-menthol formulations and related methods
#339Oral pharmaceutical composition
#340SEMI-PERMEABLE CAPSULAR MEMBRANE WITH TAPERED CONDUITS FOR DIABETES FUNCTIONAL CURE
#341Delayed-release formulations, methods of making and use thereof
#342Compositions for treatment of attention deficit hyperactivity disorder
#343Pharmaceutical products
#344DRUG DELIVERY SYSTEMS AND RELATED METHODS OF USE
#345Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
#346Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
#347Methods of treatment of attention deficit hyperactivity disorder
#348Clinical grade sodium alginate for microencapsulation of myofibroblasts isolated from wharton jelly for prevention and treatment of autoimmune and inflammatory diseases
#349Core-shell particles, preparation process thereof, and composition containing the same
#350Pharmaceutical activated carbon composition
#351NUTRITIONAL FOOD AND FEED, COMPOSITION, PROCESSING AND METHOD OF USE
#352Protective Supplement Configuration
#353Method of treatment of attention deficit hyperactivity disorder
#354Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates
#355Compositions for treatment of attention deficit hyperactivity disorder
#356PHARMACEUTICAL COMPOSITIONS OF PROTON PUMP INHIBITOR
#357Transdermal formulation containing COX inhibitors
#358Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
#359Multi-encapsulated formulations made with oxidized cellulose
#360Cross-linked polymer particles
#361Encapsulation system
#362Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
#363COMPOSITION COMPRISING A BENZIMIDAZOLE AND PROCESS FOR ITS MANUFACTURE
#364Fortified micronutrient salt formulations
#365NOVEL FORMULATIONS OF NITROFURANS INCLUDING NIFURTIMOX WITH ENHANCED ACTIVITY WITH LOWER TOXICITY
#366Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
#367Formulations
#368Compositions and methods for oxalate reduction
#369Pharmaceutical compositions for the coordinated delivery of NSAIDs
#370Methods for treatment of attention deficit hyperactivity disorder
#371ANTIRETROVIRAL COMPOSITION
#372CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION INCLUDING TAMSULOSIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND ORAL FORMULATION INCLUDING THE SAME
#373Multiparticulate L-menthol formulations and related methods
#374Reversible, on-demand generation of aqueous two-phase microdroplets
#375Enteric coated multiparticulate composition with proteinaceous subcoat
#376Enteric coated multiparticulate composition with proteinaceous subcoat
#377Escalating dosing regimen for effecting weight loss and treating obesity
#378Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#379Multiparticulate L-carnitine compositions and related methods
#380Multilayer microencapsulated probiotic bacteria
#381Compositions for treatment of heart failure in dogs
#382Enteric coated multiparticulate controlled release peppermint oil composition and related methods
#383Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#384Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#385Drug delivery product and methods
#386Enteric coated multiparticulate composition with proteinaceous subcoat
#387Abuse deterrent compositions and methods of use
#388Abuse deterrent compositions and methods of use
#389Tamper resistant pharmaceutical formulations
#390Orally disintegrable tablets
#391Tamper resistant dosage form comprising an adsorbent and an adverse agent
#392Modified release pharmaceutical compositions of dexlansoprazole
#393PHARMACEUTICAL COMPOSITIONS COMPRISING 40 - O - ( 2 - HYDROXY) ETHYL - RAPAMYCIN
#394Compositions for treatment of attention deficit hyperactivity disorder
#395Compositions for treatment of attention deficit hyperactivity disorder
#396Methods for treatment of attention deficit hyperactivity disorder
#397Taste-masked pharmaceutical compositions containing diclofenac
#398Escalating dosing regimen for effecting weight loss and treating obesity
#399CONTROLLED RELEASE PREPARATION
#400CONTROLLED RELEASE PREPARATION
#401Stable digestive enzyme compositions
#402Pharmaceutical composition
#403Pharmaceutical compositions for the coordinated delivery of NSAIDs
#404Method and compositions for producing hydrogel capsules coated for low permeability and physical integrity
#405Encapsulated cells for hormone replacement therapy
#406Multifunctional nanoparticle designs and applications
#407Gastroresistant pharmaceutical formulations containing rifaximin
#408Solventless mixing process for coating pharmaceutical ingredients
#409WATER-SOLUBLE DRUG CARRIER AND PROCESS FOR PRODUCING THE SAME
#410Multi-encapsulated microspheres made with oxidized cellulose for in-situ reactions
#411Compositions and methods for treating respiratory disorders with doxofilline
#412Multiparticulate L-menthol formulations and related methods
#413DRUG DELIVERY SYSTEM
#414Method and system using relays with aggregated spectrum
#415CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATE
#416Formulations and Methods for Attenuating Respiratory Depression Induced by Opioid Overdose
#417Multiparticulate L-menthol formulations and related methods
#418Formulations
#419Microencapsulated probiotic substance and process of manufacture
#420Oxidized cellulose miczrospheres including visualization agents
#421Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
#422Pharmaceutical cyclosporin compositions
#423Sustained Release Composition of Memantine
#424Lipid-polymer hybrid particles
#425Composition comprising a benzimidazole and process for its manufacture
#426TDF-related compounds and analogs thereof, analogs and bioactive fragments
#427Cross-linked polymer particles
#428PHARMACEUTICAL COMPOSITIONS OF (R)-LANSOPRAZOLE
#429pH-dependent gradual release pharmaceutical composition
#430DRUG DELIVERY SYSTEMS AND METHODS OF USE
#431Microcapsules and production thereof
#432Polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof
#433Encapsulation device, medical capsules, and encapsulation method
#434Solid dosage forms comprising an enteric coating with accelerated drug release
#435Formulations for oral delivery of adsorbents in the gut
#436CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION INCLUDING TAMSULOSIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND ORAL FORMULATION INCLUDING THE SAME
#437Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
#438METHOD FOR STABLE AND CONTROLLED DELIVERY OF (-)-HYDROXYCITRIC ACID
#439Controlled Release Formulations of Opioids
#440Multicarotenoid beadlets and related method
#441GASTRIC ACID SECRETION INHIBITING COMPOSITION
#442Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent
#443MULTIPARTICULATE S-ADENOSYLMETHIONINE COMPOSITIONS AND RELATED METHODS
#444Coating composition
#445METHOD AND COMPOSITION FOR STABLE AND CONTROLLED DELIVERY OF (-)-HYDROXYCITRIC ACID
#446TECHNOLOGY FOR PREVENTING ABUSE OF SOLID DOSAGE FORMS
#447Pharmaceutical composition
#448Technology for Preventing Abuse of Solid Dosage Forms
#449MULTIPARTICULATE 5-HTP COMPOSITIONS AND RELATED METHODS
#450Multiparticulate L-carnitine compositions and related methods
#451PARTICULATE PREPARATION AND METHOD FOR PRODUCING THE SAME
#452Methods and compositions for treatment of attention deficit disorder
#453NESTED CELL ENCAPSULATION
#454BARRIER COMPOSITION
#455Oral pharmaceutical composition
#456EPSILON-POLY-LYSINE CAPSULES
#457METHOD OF ADMINISTERING AN ACTIVE INGREDIENT USING A CHEWABLE ORAL DOSAGE FROM COMPRISING TEXTURE MASKED PARTICLES
#458Controlled release compositions of gamma-hydroxybutyrate
#459Method for producing pancreatin pellets
#460Multiparticulate L-menthol formulations and related methods
#461Water-soluble drug carrier and process for producing the same
#462Pharmaceutical compositions for the deterrence and/or prevention of abuse
#463MULTILAYERED POLYELECTROLYTE-BASED CAPSULES FOR CELL ENCAPSULATION AND DELIVERY OF THERAPEUTIC COMPOSITIONS
#464Pharmaceutical Compositions
#465Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates
#466DELAYED RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#467Composition comprising oil drops
#468Timed, pulsatile release systems
#469MULTI-PHASE MICROPARTICLES AND METHOD OF MANUFACTURING MULTI-PHASE MICROPARTICLES
#470Gastric Acid Secretion Inhibiting Composition
#471MULTI-LAYER TABLET COMPRISING EFFERVESCENT LAYER
#472ORAL FORMULATIONS
#473Method And Apparatus For Continuous Removal Of Submicron Sized Particles In A Closed Loop Liquid Flow System
#474Orally Disintegrating Dosage Forms Containing Taste-Masked Active Ingredients
#475Protective coatings for acidic active ingredients
#476Extended release pharmaceutical compositions
#477Pharmaceutical compositions for the coordinated delivery of NSAIDs
#478Growth promotion of animals by simultaneous release of steroid compounds from a device
#479NANOPARTICULATE COMPOSITIONS OF POORLY SOLUBLE COMPOUNDS
#480Reconstitutable microsphere compositions useful as ultrasonic contrast agents
#481Compositions comprising solid particles entrapped in collapsed polymeric microspheres, and methods of making the same
#482Pharmaceutical Compositions
#483Nanoparticle compositions and methods for improved oral delivery of active agents
#484LEVETIRACETAM CONTROLLED RELEASE COMPOSITION
#485Controlled release micro-capsule for osteogenic action
#486Multiple-layer immune barrier for donor cells
#487Modified release pharmaceutical compositions of dexlansoprazole
#488Enteric formulation of duloxetine and its core and preparation method
#489MULTICOATED ALISKIREN FORMULATIONS
#490Melt-coated pharmaceutical composition with fast release
#491Pharmaceutical compositions for release control of methylphenidate
#492MASKED TASTE PHARMACEUTICAL GRANULES/GRANULATES
#493USE OF MICROPARTICLES CONTAINING GENETICALLY MODIFIED CELLS IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
#494Controlled Release Formulations of Opioids
#495Dosage form containing (S)-pantoprazole as active ingredient
#496Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
#497Method and system using relays with aggregated spectrum
#498ANTI-SNORING TREATMENT COMPRISING POSITIVELY CHARGED MULTILAMELLAR MICROPARTICLES
#499ORAL PHARMACEUTICAL FORMULATION FOR OMEPRAZOLE COMPRISING A SPECIFIC SEPARATION LAYER
#500Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture
#501Stable digestive enzyme compositions
#502Stable digestive enzyme compositions
#503Targeting of innate immune response to tumor site
#504EXTENDED-RELEASE DOSAGE FORM
#505Stable digestive enzyme compositions
#506MODIFIED RELEASE NIACIN FORMULATIONS
#507Vegetarian microcapsules
#508SELF-MICROEMULSIFYING SYSTEMS INCORPORATED INTO LIQUID CORE MICROCAPSULES
#509HUMIDITY-RESISTANT DRUG FORMULATIONS AND METHODS OF PREPARATION THEREOF
#510Microcapsules having multiple shells and method for the preparation thereof
#511MULTIMICROPARTICULATE PHARMACEUTICAL FORMS FOR ORAL ADMINISTRATION
#512Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
#513COMBINATIONS OF NIACIN AND AN OXICAM
#514ORALLY DISINTEGRABLE TABLETS
#515COMPOSITION COMPRISING A MIXTURE OF ACTIVE PRINCIPLES, AND METHOD OF PREPARATION
#516ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS
#517Pancreatine pellets and method of producing same
#518Encapsulation of oxidatively unstable compounds
#519Taste Masked Oral Composition of Telithromycin
#520USE OF 5-AMINOLEVULINIC ACID AND DERIVATIVES IN A SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSIS
#521Device and method for preparing microparticles
#522Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics
#523Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
#524Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs
#525Gastroresistant Pharmaceutical Formulations Containing Rifaximin
#526SHUTTER DEVICE FOR CAMERA
#527PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS
#528Pharmaceutical composition of tacrolimus
#529Controlled release preparation
#530Controlled release preparation
#531METHOD FOR STABLE AND CONTROLLED DELIVERY OF (-)-HYDROXYCITRIC ACID
#532NANOCELL DRUG DELIVERY SYSTEM
#533COATING TECHNOLOGY TO PRODUCE A COMBINATION SOLID DOSAGE FORM
#534CONTROLLED RELEASE PREPARATION
#535Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
#536Stable digestive enzyme compositions
#537STABILIZED ANTIOXIDANT PARTICLES, COMPOSITION COMPRISING THE SAME AND METHOD FOR PREPARING THE SAME
#538Oral pharmaceutical composition
#539COLONIC DELIVERY OF ANTIMICROBIAL AGENTS
#540PHARMACEUTICAL NIMODIPINE COMPOSITIONS
#541Drug delivery product and methods
#542COMBINATION PHARMACEUTICAL COMPOSITIONS
#543Microcapsule Nanotube Devices for Targeted Delivery of Therapeutic Molecules
#544Micro-particles, blood-substitute and method for forming same
#545Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug level
#546Pharmaceutical compositions of duloxetine
#547TDF-related compounds and analogs thereof, analogs and bioactive fragments
#548Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
#549Nanoparticles for cytoplasmic drug delivery to cancer cells
#550Spheroids and multiparticulate tablets comprising them
#551Pharmaceutical cyclosporin compositions
#552GASTRORESISTANT PHARMACEUTICAL DOSAGE FORM COMPRISING N-(2-(2- PHTHALIMIDOETHOXY)-ACETYL)-L-ALANYL-D-GLUTAMIC ACID (LK-423)
#553CONTROLLED RELEASE COMPOSITION AND PREPARATION THEREOF
#554Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole
#555MULTI-MEMBRANE IMMUNOISOLATION SYSTEM FOR CELLULAR TRANSPLANT
#556Methods and Compositions for the Treatment of Viral Infections
#557Gastric acid secretion inhibiting composition
#558ORAL SUBMICRON PARTICLE DELIVERY SYSTEM FOR PROTEINS AND PROCESS FOR ITS PRODUCTION
#559Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
#560GRANULAR PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#561Solid dosage forms comprising an enteric coating with accelerated drug release
#562STABLE, DURABLE GRANULES WITH ACTIVE AGENTS
#563Compositions of microparticles and granules for oral controlled release of substances for veterinary use
#564MICROCAPSULES HAVING MULTIPLE SHELLS AND METHOD FOR THE PREPARATION THEREOF
#565DIPYRIDAMOLE AND ACETYLSALICYLIC ACID FORMULATIONS AND PROCESS FOR PREPARING SAME
#566Methods, Compositions and Device for Directed and Controlled Heating and Release of Agents
#567Use of Sucralose as a Granulating Agent
#568Stable digestive enzyme compositions
#569METHOD FOR PREPARING PARTICLES COMPRISING METAL OXIDE COATING AND PARTICLES WITH METAL OXIDE COATING
#570Non-covalent modification of microparticles and process of preparing same
#571Modified Release Pharmaceutical Composition of Bupropion Hydrochloride
#572Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor Antagonists
#573NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS
#574Escalating dosing regimen for effecting weight loss and treating obesity
#575Method for the Encapsulation and Controlled Release of Poorly Water-Soluble (Hyprophobic) Liquid and Solid Active Ingredients
#576Method For Ultrasound Triggered Drug Delivery Using Hollow Microbubbles With Controlled Fragility
#577RECONSTITUTABLE MICROSPHERE COMPOSITIONS USEFUL AS ULTRASONIC CONTRAST AGENTS
#578MULTIFUNCTIONAL POLYMERIC TISSUE COATINGS
#579Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
#580Composition and method for treating or preventing white spot syndrome virus
#581COMPOSITIONS COMPRISING WEAKLY BASIC DRUGS AND CONTROLLED-RELEASE DOSAGE FORMS
#582Nanoencapsulation and Release of Nucleic Acids
#583Method and process for the production of multi-coated recognitive and releasing systems
#584Method and process for the production of multi-coated recognitive and releasing systems
#585Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising Same
#586Controlled Release Muscarinic Receptor Antagonist Formulation
#587IMPROVED PHARMACOKINETIC PROFILE OF BETA-ADRENERGIC INVERSE AGONISTS FOR THE TREATMENT OF PULMONARY AIRWAY DISEASES
#588Porous Drug Delivery Devices and Related Methods
#589TABLETS COMPRISING CANDESARTAN CILEXETIL
#590Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets
#591Particle immobilized coatings and uses thereof
#592Pharmaceutical safety dosage forms
#593Zolpidem pharmaceutical compositions
#594Pharmaceutical compositions
#595Pharmaceutical composition
#596Immediate disintegration polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof
#597Compositions Comprising Solid Particles Entrapped In Collapsed Polymeric Microspheres, And Methods Of Making The Same
#598CARBAMAZEPINE FORMULATIONS
#599Pharmaceutical Compositions
#600Bacteriophage composition